Data for more aortic simulator shows the ability to blindly place end of shunt and substantially control hemorrhage in under 30 seconds. Data was collected over five trials, validating the ease of use and rapid efficacy of EndoShunt.
The information on this website is for general informational purposes only. EndoShunt does not make marketing claims or assertions about device capabilities, and device’s regulatory status is subject to change and has not been evaluated by the FDA. Consult healthcare professionals for medical advice.
© Copyright 2023. All Rights Reserved. EndoShunt Developed By Expand More